Pharmaceuticals 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 17.
Husqvarna Group Capital Markets Day
Husqvarna Group today holds its capital markets day, with presentations to the
financial community and media. The capital markets day includes presentations by
the Group’s CEO, CFO, the business area heads and other members of Group
Management, with special focus on strategic priorities and activities.
At the event, Hans Linnarson, President and CEO, comments on the Group’s
financial targets. Three of the four targets remain; to achieve an operating
margin of more than 10% over the course of a
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Husqvarnakoncernens kapitalmarknadsdag
I dag hålls Husqvarnakoncernens kapitalmarknadsdag för finansmarknaden och
media. Presentationer hålls av koncernens VD, finansdirektör, chefer för
affärsområdena och andra medlemmar i koncernledningen. Särskilt fokus sätts på
strategiska prioriteringar och aktiviteter.
VD och koncernchef Hans Linnarson tar under dagen upp koncernens finansiella
mål. Tre av fyra mål kvarstår: rörelsemarginal som överstiger 10% över en
konjunkturcykel, att den säsongsjusterade nettoskulden i relation till EBITDA
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
HALDEX YEAR-END REPORT 2012
Q4: Strong cash flow on lower volumes
Haldex Group, October – December 2012
· Sales amounted to SEK 864 m compared to SEK 1,035 m in the corresponding
period last year, primarily due to the continued destocking in Q4, especially in
December. Adjusted for exchange rate fluctuations, sales decreased 14% compared
with the same period (Q4) prior year.
· Operating income and operating margin excluding restructuring costs amounted
to SEK 34 m (49) and 3.9% (4.8), respectively. Operating income an
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
DIBS Boks.skommuniké januari – december 2012
Stockholm den 14:e februari 2013
Jan – dec 2012 i sammandrag
· Nettoomsättningen 155,1 Mkr (150,7) + 3 %
· Rörelseresultatet 20,8 Mkr (29,0) - 28 %
· Resultatet efter skatt 14,8 Mkr (21,7) - 32 %
· Resultatet per aktie 1,54 kr (2,26) - 32 %
· Andelen återkommande intäkter 90 % (89 %)
· Nettoinflödet av antalet kunder 803 (1 545) - 48 %
· Antal kunder 14 801 (13 998) + 6 %
· Kundernas transaktionsvärde 94,3 Mdr (82,0) + 15 %
· EBITDA 29,8 Mkr (35,2) - 15 %
· EBITDA-marginal 1
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Rezidor Hotel Group: Year-End Report January-December 2012
Fourth quarter, 2012
* Like-for like ("L/L") RevPAR was up by 4.2%.
* Revenue increased by 6.6% to MEUR 240.6 (225.6).
On a L/L basis Revenue increased by 2.8%.
* EBITDA amounted to MEUR 15.6 (14.1), and the EBITDA margin to 6.5% (6.3).
* Loss after tax amounted to MEUR -13.3 (-13.5), negatively impacted by
termination costs due to exit of contracts of MEUR -9.4 (0.0), write-downs
of assets of MEUR -6.7 (-9.9) and a write-down of deferred tax assets of
MEUR -3.3 (-8.5).
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Active Biotech AB Year-end report January - December 2012
Events for the full year 2012
Laquinimod
* Phase III data presented at the AAN (64th Annual Meeting of the American
Academy of Neurology)
* Application submitted for regulatory approval in the EU, milestone payment
of USD 5 M from Teva
* Teva initiates a Phase III study in multiple sclerosis (the CONCERTO study)
in the US
* Positive Crohn's Phase II data presented at the UEGW conference
* Teva expands the clinical development program to encompass new indications
TASQ
*
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Enea renews development and production license agreement worth 13.3 MEUR
STOCKHOLM, Sweden, 14 February, 2013 – Enea (NASDAQ OMX Nordic:ENEA) has signed
an agreement with a European customer. Today’s agreement, worth 13.3 MEUR (111
MSEK) is a renewal of a previous agreement for the operating system Enea OSE. It
includes development licenses, production licenses and support for a two year
period.
“We are continuously investing in our key accounts and today’s agreement is
clearly a proof of renewed trust. The customer has been increasingly successful
and we therefor a
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Rezidor Hotel Group: Boks.skommuniké januari-december 2012
Fjärde kvartalet, 2012
* RevPAR för jämförbara hotell ("L/L") ökade med 4,2%.
* Intäkterna ökade med 6,6% till 240,6 MEUR (225,6).
Intäkterna för jämförbara hotell ökade med 2,8%.
* EBITDA uppgick till 15,6 MEUR (14,1) och EBITDA-marginalen till 6,5% (6,3).
* Förlust efter skatt uppgick till -13,3 MEUR (-13,5), negativt påverkad av
kostnader för avs.ade kontrakt om -9,4 MEUR (0,0), nedskrivningar av
anläggningstillgångar om -6,7 MEUR (-9,9), samt nedskrivning av uppskjutna
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Active Biotech AB Boks.srapport januari - december 2012
Händelser under helåret 2012
Laquinimod
* fas III-data presenterade på AAN (64th Annual Meeting of the American
Academy of Neurology)
* registreringsansökan inlämnad i EU, 5 MUSD i delmålsersättning från Teva
* Teva initierar fas III-studie i multipel skleros (CONCERTO-studien)
* positiva fas II-data för Crohns sjukdom presenterade på konferensen UEGW
* Teva utvidgar det kliniska prövningsprogrammet med nya indikationer
TASQ
* 10 MEUR i delmålsersättning från Ipsen vid uppnått
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Outokumpu - Notice to the Annual General Meeting
OUTOKUMPU OYJ
STOCK EXCHANGE RELEASE
February 14, 2013 at 9.30 am EET
Notice is given to the shareholders of Outokumpu Oyj to the Annual General
Meeting to be held on Monday, March 18, 2013 at 12.00 pm. at Marina Congress
Center, address: Katajanokanlaituri 6, 00160 Helsinki, Finland.
The reception of persons who have registered for the meeting and the
distribution of voting tickets will commence at 11.00 am.
A. Matters on the agenda of the Annual General Meeting
At the Annual Ge
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Outokumpu - Share-based incentive schemes
OUTOKUMPU OYJ
STOCK EXCHANGE RELEASE
February 14, 2013 at 9.30 am EET
Outokumpu’s Board of Directors has approved the commencement of the second plan
of Performance Share Plan 2012, plan 2013–2015 and its participants. The Board
of Directors has also confirmed the outcome of the earning period 2010–2012 of
the share-based incentive scheme 2009–2013 and harmonized the earning criteria
of the on-going plans with the new plan 2013–2015.
Performance Share Plan, earning period 2013–2015
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
Indreværdi for Alm. Brand Formue A/S.
Indreværdi er den 14. februar 2013 opgjort til kr. 115,18
Source: Medical News (via PRIMEZONE) - February 14, 2013 Category: Pharmaceuticals Source Type: news
RxISK.org’s Dr. Healy Coming to Talk to U.S. Audiences About Deadly...
How often do prescription medications cause people to do things they would never normally do?(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10415466.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Leading Scottsdale Pain Management Clinic, Arizona Pain Specialists,...
Arizona Pain Specialists, the leading Scottsdale pain management clinic, has...(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/painmanagementscottsdale/azpaincenter/prweb10415449.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
hCG Treatments / Diet Doc hCG Diets & Weight Loss Plans Announces...
Diet Doc has formulated the most potent refined coconut oil, known as MCT, which will generate fat burning within the body in as little as 30 minutes.(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/mct-weight-loss-oil/fast-weight-loss/prweb10414487.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
WriteResult Releases White Paper on Utilizing Digital Pen for ePRO
Provides an overview of the technology and practical guide for successful implementation in the clinical setting.(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10404724.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Notes FDA Finding...
The Firm is currently investigating legal claims on behalf on individuals who suffered metallosis, premature device failure and other serious complications, allegedly due to metal-on-metal hip...(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/metal-on-metal-hip/all-metal-hip-implants/prweb10418455.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
DePuy ASR Hip Lawsuits: Bernstein Liebhard LLP Continues to Monitor...
The Firm is actively filing DePuy ASR lawsuits on behalf of individuals who experienced premature device failure, metallosis and other complications allegedly due to the recalled hip implant.(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/depuy-asr-hip-lawsuits/depuy-asr-hip-trial/prweb10418378.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Corporate Whistle Blower Center Now Urges Physicians To Cash In If...
The Corporate Whistle Blower Center is now urging a physician, or physicians in the US, or anywhere in the world who possess significant proof a...(PRWeb February 11, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10414744.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Research and Markets Announces the Addition of "Global Flow...
Trimark Publications report's "Global Flow Cytometry Market" provides a detailed analysis of one of the fastest-growing segments of life sciences and clinical diagnostics markets. It is...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10423195.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Healthcare Data Solutions Announces New Prescriber Validation...
Healthcare Data Solutions announced a new service, PVSS, that will help reduce the risk of fines and audits and ensure pharmacy compliance by allowing clients to send real-time inquiries to determine...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421376.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Eastern Clinical Trials Russia CRO Passes EMA Inspection
Eastern Clinical Trials Russia CEE CRO passes EMA Inspection for oncology clinical trial.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421281.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Focalin Coupon Card Makes ADHD Medication Affordable
Focalin discount cards from AffordRx are helping families and individuals nationwide afford their ADHD medications.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421275.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
The MedZilla.com Employment Report for February, 2013: Health Care...
MedZilla Reports: The Bureau of Labor reported Friday that while the overall unemployment average remained steady, the economy was still able to add 157,000...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421163.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
Nano3D Biosciences (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology and life science research markets, announces the release of...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/n3dbiosciences/newproduct/prweb10420438.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
NSG Precision Cells Has Updated its Fluorescence Cell Line with New...
Over the last few months, NSG Precision has unleashed a comprehensive new fluorescence cell line for its customers with...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10420074.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces...
Diet Doc has released new prescription only Slim Down diet pills for safe and fast weight loss.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/diet-pills/hcg-diets/prweb10420010.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Fathom Named Among ‘Best SEO Companies’ in USA, ‘Largest Advertising...
New national and local honors put Fathom in select company for SEO and digital marketing.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/best-seo-companies/fathom-awards/prweb10420000.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Rehmani Consulting, Inc. Provides the Training Platform that IT...
Rehmani Consulting, Inc. offers a training platform for Microsoft® SharePoint® that enterprise IT organizations can use to provide business users with the training assets they require to be...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/SharePoint/Solutions/prweb10419406.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Critical Milestone Achieved in NaF Clincial Trials: 500+ Patients...
The World Molecular Imaging Society (WMIS) announced today that over 500 patients are now enrolled in the Sodium Fluoride NaF clinical trial (18F-Fluoride PET/CT Versus 99mTc-MDP Scanning for...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10418219.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
d’Oliveira & Associates Issues Webpage With Current Information On...
d’Oliveira & Associates Issues Press Release With Current Information On Transvaginal Mesh Patch Lawsuits(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10413801.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Compounding Pharmacy Crackdown to Go Nationwide, Ruggio Predicts
LeClairRyan attorney says officials in several states—not just Massachusetts and New Jersey—are ramping up scrutiny of compounding pharmacies in the wake of a deadly fungal meningitis outbreak.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10413074.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Wohl Associates Offers New Packaging Machinery Including Pressure...
Wohl Associates announces new packaging machinery for sale including pressure sensitive labelers. The used machinery dealer has increased their packaging inventory to include more than 150 machines.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/pressure-sensitive-label/wohl-associates/prweb10409702.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
New Snacks from CME Outfitters’ 5th Annual Chair Summit Go Live
CME Outfitters’ multimedia CME Snacks from Chair Summit are now available online for clinicians seeking quick and easy neuroscience CME credit.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10356001.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
University of Colorado Cancer Center Study Shows That Problem-Solving...
Multi-site clinical trial proves the effectiveness of Bright IDEAS problem-solving training in reducing symptoms of posttraumatic stress in mothers of children diagnosed with cancer. Materials...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10424402.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Fosamax Lawsuits Surpass 800 in Federal Fosamax Femur Fracture...
The Firm is currently investigating Fosamax lawsuits on behalf of individuals who suffered femur fractures, allegedly due to their use of Fosamax.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/fosamax-lawsuits/fosamax-femur-fractures/prweb10424327.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
DePuy ASR Hip Recall: Bernstein Liebhard LLP Comments on New Evidence...
The Firm is actively filing DePuy ASR lawsuits on behalf of individuals affected by the 2010 DePuy ASR recall.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/depuy-asr-hip-recall/depuy-asr-hip-lawsuit/prweb10423268.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Industry Executives to Explore the Future of Life Sciences Research...
Knowledgent, a leading industry information consultancy focused on maximizing the value of information to empower clients with actionable business insights, is convening industry executives and...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421257.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
DynaClean Conveyor Leg Support Design Improved
Food Processing Conveyor has newly redesigned leg supports for improved sanitation(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10420086.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
QuantumDigital Launches QuantumPostcards, Targeted Postcard Marketing...
QuantumDigital has launched QuantumPostcards™, an online storefront for small business owners that makes targeted direct mail postcard and print marketing simple and fast.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/QuantumPostcards/QuantumDigital/prweb10417958.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Healthcare Solutions Appoints Joe Boures to the Position of President...
Work comp industry executive, Joe Boures, has been promoted to president and COO of Healthcare Solutions.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10413209.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
zuChem and Godavari Partner to Commercialize Renewable Manufacturing...
zuChem Inc. and Godavari Biorefineries Ltd. announced they have entered into a global partnership combining zuChem’s xylitol technology platform with Godavari’s leadership position in the production...(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10427940.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Institute of Medicine Report on Drug Safety Omits Research Showing...
The Institute of Medicine's drug safety report, "Countering the Problem of Falsified and Substandard Drugs" aptly addresses many problems of drug safety but omits the facts about online...(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/IOM-report-ignores-facts/online-pharmacies/prweb10427671.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
MedMar Healing Center Offers Summary of Ongoing Research Study Results
MedMar Healing Center, a medical marijuana dispensary located in downtown San Jose, reports summary of ongoing research study on the effects of Cannabidiol (CBD).(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10426129.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces a...
Diet Doc offers the most advanced, noninvasive weight loss diet for teens with medically monitored prescription hCG diet plans.(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/baritric-surgery/hcg-diet-plans/prweb10424761.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
RxNetwork Releases Innovative Consumer-Engagement Platform To Improve...
RxNetwork, a Washington, D.C.-based, consumer-engagement, healthcare IT startup has developed and plans to release an integrated platform that connects pharmacies with their patients while addressing...(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421092.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
CenterLight Health System Goes Live with Osprey’s Conflict of Interest...
--Osprey COI RiskManager™ Automates Disclosure Management and Facilitates Compliance --(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10420536.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
US Compounding Announces Addition of TriMix-gel
TriMix-gel is the Newest Product in US Compounding Strategy(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10419786.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Overcome Opiate Addiction with the 12 Month Comprehensive Outpatient...
Five Points Wellness and Recovery: A 12-Month Bio-Psycho-Social Intensive Outpatient
Treatment Program Utilizing Suboxone, Psychotherapy, Wellness and Occupational Support(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10419052.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
TalkPoint and FDAAdvisoryCommittee.com partner for series of FDA...
Workshop will discuss minimal residual disease (MRD) as a possible response in group of hematological malignancies(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/TalkPoint/FDAAC/prweb10418062.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
